A digital workflow,
built around the way you scale.

The discovery work with the Point Designs clinical and engineering team converged on a single observation: the current workflow is technically capable but structurally capped. The team can produce excellent partial-hand sockets, but every axis of growth — designer count, throughput, international expansion, customer empowerment — runs into either a per-seat license tax, a labor floor set by physical plaster handling, or a tooling stack that fundamentally cannot be put in front of an external clinician.

Three constraints define that ceiling today. The phased project below resolves each in sequence, without forcing PD to commit to phases 2+ before phase 1 is validated in production.

"Our current model doesn't scale at all with enabling customers to be more involved in the process… we can't achieve this vision if our model relies on access to Freeform+ and a haptic device."— Point Designs, scoping questionnaire

What this partnership delivers

A browser-native design environment owned and operated by Point Designs, replacing the Freeform-based workflow over 12 months. Designed first for the internal team — the diagnostic-device workflow (Phase 1) — then extended to the definitive device, finger alignment, and a clinician-facing workflow for distributors worldwide (Phase 2). Delivered under a single fixed development fee that includes engineering, software licenses, and operational use during the build.

Each phase delivers a tool that PD can use in production before the next phase begins. The gate is explicit and verifiable — Phase 2 does not start until Phase 1 has passed clinical adherence review. This protects both parties: PD doesn't pay for capability they haven't validated; Spentys doesn't build on requirements that haven't survived contact with real patients.

The shipment chain, before and after

Phase descriptions below are deliberately specific about what is out of scope at each stage. This is the single most common source of cost overrun in partnership programs and the easiest to prevent at scoping time. The engagement is two phases: a diagnostic-device workflow built for the internal team first, then the definitive-device and alignment workflow extended to clinicians.

The fixed development fee funds a defined, costed engineering build. Decomposed sub-process by sub-process in the internal scope map, the work totals 62 engineering-days across three tracks — App, OMS, and Device — split Phase 1 29.5 days / Phase 2 32.5 days. The 12-month calendar is paced by the clinical-adherence validation gate and by Point Designs’ own material and closure R&D — not by engineering hours — so focused build sprints sit inside a schedule held open for review. Spentys provides the team and absorbs all coordination overhead; PD does not staff the engineering build — its commitment is the clinical-reviewer, patient-cohort and onboarding time noted at the gates (§03 / §07).

Engineering load across 12 months

Days & tracks, mapped to the timeline

Every block below represents one discipline's commitment within a phase. Block opacity scales with weekly intensity — heavier blocks are where the work concentrates. Discipline totals sit on the right; phase totals on the bottom. Phases align with the timeline Gantt in §02 and the load curve above.

Days are committed at the phase level; Spentys retains flexibility to rebalance tracks within each phase to deliver acceptance criteria. Phase totals are fixed; PD does not staff the engineering build.

The commercial structure is built to match how Point Designs actually buys: a fixed development fee for budget predictability, predictable per-product expansion pricing for the multi-year roadmap, and a tiered license that scales with usage without becoming a per-click tax.

What the development fee includes

"In Phase 1, we need to carefully evaluate the cost model relative to our current system. If the recurring SaaS license fees and click fees are high, then it actually may be more costly to develop and use this digital tool than it would be to just buy more Freeform licenses and hire more people."— Point Designs, scoping questionnaire

The three-component structure is designed specifically to answer this concern. The development fee is fixed. The license is tiered with volume discounts that reward growth rather than penalising it. Per-product-line expansion is quoted in advance at $19k each so the multi-year roadmap is fully budgetable from day one. There are no per-click fees, no escalating SaaS surprises, and no per-seat scaling tax during the 12-month build. Work requested outside the agreed scope during the build is billed separately at a variable hourly rate of $120/hour (time-and-materials, ≈ $960/day) — billed by the hour so even small change requests are accessible and priced fairly, the fixed fee stays fixed, and nothing turns into a renegotiation.

There is a clock on this. Since 1 April 2026, US partial-hand reimbursement codes have been cut — reductions reported between 20% and 80%. The way to protect margin under the new codes is to reduce the time spent per patient and per case. That makes the efficiency case below not just an ROI exercise but a direct response to a live external pressure.

PD set the benchmark themselves: if the partnership costs more than buying additional Freeform licenses, haptic devices, and hiring designers to handle the projected growth from ~400 to 800–1,000 units, it isn't worth doing. The math below uses PD's stated baselines and the Geomagic pricing PD provided, scoped to the same 12-month window as the development fee.

Path A — Status quo: scale through hiring and licenses

Operational savings beyond the headline

The figures above only count the avoided cost of scaling. The partnership also reduces per-case operating cost on every fabrication PD already does today. Point Designs' own targets from the workflow review:

• Total workflow time: the full journey — administrative, O&P, and related steps — currently runs 30–40 hours. PD's target is roughly 13 hours, largely by reducing time spent with the patient.
• Throughput without linear hiring: today ~2 designers produce ~400 units/yr (~25/month average, ~50/month ceiling). Path A reaches 800–1,000 units only by adding designers, seats and haptics in proportion; the digital workflow instead lifts per-designer throughput by removing the plaster-labor floor and cutting per-case design time, so volume scales toward the target without a matching headcount step.
• Diagnostic device production: ~4 hours of labor today (pour, scan, modify, build liner, design). Phase 1 removes the plaster-modification and Freeform design labor via the digital workflow and printed PA12 frame; once the printable (TPU) liner comes online in Phase 2, diagnostic production targets about 1 hour.
• Manual alignment: currently 1–2 hours per case; the digital alignment workflow targets roughly 10% of that.
• Shipping & customs: cutting the chain from five shipments to three removes direct cost (~$25 domestic, ~$100 international per shipment) plus ~10 min prep each and customs friction — on exactly the international population PD wants to grow.
• International expansion without new sites: replicating the current process abroad would mean opening a location and training silicone-liner staff over 6–12 months. A digital workflow with printable diagnostics (PA12 frame from Phase 1; printed liner from Phase 2) avoids that entirely — and avoids additional Geomagic Freeform license cost.

Path A figures based on a fully-loaded US designer salary of $100k/yr (base + benefits + overhead) and Geomagic Freeform pricing of $22,000 upfront plus $3,500/year per license, as stated by Point Designs. A higher-loaded senior salary would push the comparison further in favor of the partnership. Path B compares the Year-1 fixed commitment only; the tiered license activates after rollout and is volume-scaled rather than per-seat. Per-product expansion priced at $19,000 per added line.